Talk:CureVac: Difference between revisions
cc tag |
→Request edit on 8 May 2018: new section |
||
Line 14: | Line 14: | ||
}} |
}} |
||
{{COI editnotice}} |
{{COI editnotice}} |
||
== Request edit on 8 May 2018 == |
|||
<!-- PLEASE READ: Please provide your requested edit after the {{request edit}} below in a roughly "replace X with Y" format. Explain the rationale behind the edit and provide reliable sources to support the proposed changes. At the end of the request, add four tildes "~~~~" and click "Save Page" --> |
|||
{{request edit}} |
|||
I would like to request the following change: CureVac has entered into a collaboration with [[Eli Lilly and Company]] in October 2017. This could be included in the list of partners at the beginning of the entry as well as in the history part. Neutral sources are e.g. |
|||
https://endpts.com/eli-lilly-is-making-a-1-8b-leap-into-the-mrna-field-targeting-next-gen-cancer-vaccines/ |
|||
and |
|||
https://www.fiercebiotech.com/biotech/lilly-curevac-pen-1-8b-mrna-cancer-vaccine-deal |
|||
Thank you for reviewing, --[[User:VerenaLauterbach CureVacAG|VerenaLauterbach CureVacAG]] ([[User talk:VerenaLauterbach CureVacAG|talk]]) 12:49, 8 May 2018 (UTC) |
Revision as of 12:49, 8 May 2018
This is the talk page for discussing improvements to the CureVac article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Articles for creation Stub‑class | ||||||||||
|
The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
Individuals with a conflict of interest, particularly those representing the subject of the article, are strongly advised not to directly edit the article. See Wikipedia:Conflict of interest. You may request corrections or suggest content here on the Talk page for independent editors to review, or contact us if the issue is urgent. |
Request edit on 8 May 2018
It is requested that an edit be made to the semi-protected article at CureVac. (edit · history · last · links · protection log)
This template must be followed by a complete and specific description of the request, that is, specify what text should be removed and a verbatim copy of the text that should replace it. "Please change X" is not acceptable and will be rejected; the request must be of the form "please change X to Y".
The edit may be made by any autoconfirmed user. Remember to change the |
I would like to request the following change: CureVac has entered into a collaboration with Eli Lilly and Company in October 2017. This could be included in the list of partners at the beginning of the entry as well as in the history part. Neutral sources are e.g. https://endpts.com/eli-lilly-is-making-a-1-8b-leap-into-the-mrna-field-targeting-next-gen-cancer-vaccines/ and https://www.fiercebiotech.com/biotech/lilly-curevac-pen-1-8b-mrna-cancer-vaccine-deal Thank you for reviewing, --VerenaLauterbach CureVacAG (talk) 12:49, 8 May 2018 (UTC)